Wolverine Asset Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Wolverine Asset Management’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-134,666	Closed	-$1.79K	–	2096
2023 Q2	$1.79K	Hold	134,666	–	–	﹤0.01%	1589
2023 Q1	$6.88K	Sell	134,666 -6,254	-4%	-$558	﹤0.01%	1503
2022 Q4	$12K	Buy	140,920 +1,000	+0.7%	+$133	﹤0.01%	1600
2022 Q3	$31K	Sell	139,920 -7,977	-5%	-$2.42K	﹤0.01%	1720
2022 Q2	$33K	Sell	147,897 -15,529	-10%	-$12.5K	﹤0.01%	1701
2022 Q1	$125K	Buy	+163,426	New	+$120K	﹤0.01%	1251

Wolverine Asset Management's GRNAW Position: Q3 2023 in Review

Wolverine Asset Management sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 134,666 shares — an estimated $1.79K sold.

Wolverine Asset Management first reported a position in GRNAW in Q1 2022 and held it in 6 quarters. The position peaked at $125K in Q1 2022. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

Wolverine Asset Management reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
Wolverine Asset Management sold 134,666 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $1.79K.
Wolverine Asset Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2022 and held it in 6 quarters.
Wolverine Asset Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $125K in Q1 2022.
1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on Wolverine Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.